Stock Financial Ratios, Dividends, Split History

KBH / KB Home financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price25.89
Volume1,126,800.00
Market Cap ($M)2,265.54
Enterprise Value ($M)1,761.61
Book Value ($M)1,852.72
Book Value / Share21.17
Price / Book1.25
NCAV ($M)0.00
NCAV / Sharen/a
Price / NCAVn/a
Share Statistics
Common Shares Outstanding 87,048,265
Weighted Average Number Of Shares Outstanding Basic 85,842,000
Weighted Average Number Of Diluted Shares Outstanding 98,316,000
Scoring Models
Piotroski F-Score4.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.09
Return on Assets (ROA)0.04
Return on Equity (ROE)0.10
Balance Sheet (mrq) ($M)
Assets4,957.10
Liabilities3,103.48
Quick Ration/a
Current Ration/a
Income Statement (mra) ($M)
Home Building Revenue4,356,265,000.00
Financial Services Revenue12,264,000.00
Revenues4,368,529,000.00
Operating Income283.40
Net Income180.59
Earnings Per Share Basic2.09
Earnings Per Share Diluted1.85
Cash Flow Statement (mra) ($M)
Cash From Operations513.22
Cash from Investing-15.74
Cash from Financing-15.74
Identifiers and Descriptors
CUSIP48666K109
Central Index Key (CIK)795266
Related CUSIPS
48666K959 48666K909

Split History

Stock splits are used by KB Home to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

Related News Stories

Pick These 4 Strong Earnings Yield Stocks for Higher Returns

15h zacks
If you are hesitant whether to invest your money in stocks or bonds, one important financial parameter that can show you the right direction is earnings yield. It is the reciprocal of the price-to-earnings (P/E) ratio. This ratio can be used for identifying undervalued stocks. Also, this ratio can be effectively utilized for comparing stocks with the market or fixed income securities. Earnings yield can be calculated as (Annual Earnings per Share/Market Price) x 100. (33-0)

Weak Homebuilder Stocks Are A Warning For The Housing Market

2018-05-20 seekingalpha
Since the end of 2012, home prices are up by an inflation-adjusted annual rate of 4.7%, well above the rate of inflation. (1-0)

Is KB Home (KBH) a Great Stock for Value Investors?

2018-05-18 zacks
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process.

Is the Slump in Starts & Permits a Real Threat to Housing?

2018-05-17 zacks
New residential construction in the United States decreased more than expected in April 2018 as lesser starts of apartment buildings overshadowed a modest improvement in single-family structures. Notably, this is the second time in the last four months that housing starts has toppled. Per the latest jointly released report from the U.S. Census Bureau and the U.S. Department of Housing and Urban Development, construction of new homes fell 3. (12-0)

Single-Family Homes Demand Bolster Builder Confidence in May

2018-05-16 zacks
Builder confidence increased two points to 70 in May from a downward revision of 68 in April, reinstating builders’ confidence in the current housing market. Importantly, the reading was above the 50 mark, in the first five months of 2018, indicating a favorable outlook. Moreover, this is the fourth time in 2018 that the index has reached 70. The National Association of Home Builders or NAHB/Wells Fargo Housing Market Index (HMI) includes builder perceptions of current single-family home sales, sales expectations for the next six months and traffic of prospective buyers. (22-0)

CUSIP: 48666K109